WHO ICTRP trial
Rituximab (Mabthera) in metastatic melanoma
EUCTR2007-005125-30-AT · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2007-005125-30-AT |
|---|---|
| Public title | Rituximab (Mabthera) in metastatic melanoma |
| Scientific title | Rituximab (Mabthera) in metastatic melanoma |
| Primary sponsor | Medizinische Universität Wien, Univ.Klinik für Dermatologie, Abteilung für Immundermatologie |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Austria |
| Conditions | metastatic melanoma patients, clinical stage IIIc/IV ( AJCC2002), disease free |
| Interventions | Trade Name: Mabthera Product Name: MabThera Product Code: EU/1/98/067/002 Pharmaceutical Form: Intravenous infusion |
| Registration date | Oct 20, 2008 |
| Secondary IDs | V1.1 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: